TELO · Telomir Pharmaceuticals, Inc. · Exempt Offerings
$1.02
+0.01 (+0.99%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report.”View the 10-Q filed Aug 13, 2026
Market Cap
$69.46M
Shares
68.77M
Volume · Oct 21
37.66K
Avg daily vol (3M)
92.59K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.